Summary Stentys SA (Stentys) is a medical technology company that develops and offers solutions to cardiologists to treat patients with acute myocardial infarction and coronary disease. The company's products include BMS and DES stents, and aspiration catheter stents. Stentys's stent is designed with small distinctive interconnectors, which is implanted in the hand vessel over a single wire. The company markets products under brand names, namely, Self-Apposing and STENTYS. It has conducted clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Stentys, SA - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Stentys SA Company Snapshot 5 Stentys SA Company Overview 5 Stentys SA Pipeline Products and Clinical Trials Overview 5 Stentys SA - Pipeline Analysis Overview 7 Key Facts 7 Stentys SA - Major Products and Services 8 Stentys SA Pipeline Products by Development Stage 9 Stentys SA Pipeline Products Overview 11 Next-Generation Delivery System 11 Next-Generation Delivery System Product Overview 11 STENTYS Paclitaxel-Eluting Stent 12 STENTYS Paclitaxel-Eluting Stent Product Overview 12 STENTYS Self-Apposing Coronary Stent 13 STENTYS Self-Apposing Coronary Stent Product Overview 13 Stentys SA - Key Competitors 14 Stentys SA - Key Employees 15 Stentys SA - Locations And Subsidiaries 16 Head Office 16 Other Locations & Subsidiaries 16 Recent Developments 17 Stentys SA, Recent Developments 17 Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 17 Mar 21, 2016: STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease 17 Mar 16, 2016: STENTYS Reports 2015 Annual Results 17 Feb 29, 2016: STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention 18 Feb 08, 2016: STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication 19 Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress 19 Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 19 Oct 15, 2015: STENTYS Reports 84% Growth in Third-Quarter 2015 Revenues 20 Oct 12, 2015: STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years 20 Sep 28, 2015: STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease 20 Appendix 22 Methodology 22 About GlobalData 22 Contact Us 22 Disclaimer 22
List of Tables
Stentys SA Pipeline Products and Clinical Trials Overview 5 Stentys SA Pipeline Products by Equipment Type 6 Stentys SA Pipeline Products by Indication 6 Stentys SA, Key Facts 7 Stentys SA, Major Products and Services 8 Stentys SA Number of Pipeline Products by Development Stage 9 Stentys SA Pipeline Products Summary by Development Stage 10 Next-Generation Delivery System - Product Status 11 Next-Generation Delivery System - Product Description 11 STENTYS Paclitaxel-Eluting Stent - Product Status 12 STENTYS Paclitaxel-Eluting Stent - Product Description 12 STENTYS Self-Apposing Coronary Stent - Product Status 13 STENTYS Self-Apposing Coronary Stent - Product Description 13 Stentys SA, Key Employees 15 Stentys SA, Subsidiaries 16
List of Figures
Stentys SA Pipeline Products by Equipment Type 6 Stentys SA Pipeline Products by Development Stage 9
Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers isRead More...
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to drivRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.